Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Public ClinicalTrials.gov record NCT03059420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.
Study identification
- NCT ID
- NCT03059420
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 20,000 participants
Conditions and interventions
Conditions
- Congenital Fibrosis of Extraocular Muscles
- Duane Retraction Syndrome
- Duane Radial Ray Syndrome
- Mobius Syndrome
- Brown Syndrome
- Marcus Gunn Syndrome
- Strabismus Congenital
- Horizontal Gaze Palsy
- Horizontal Gaze Palsy With Progressive Scoliosis
- Facial Palsy
- Facial Paresis, Hereditary, Congenital
- Third Nerve Palsy
- Fourth Nerve Palsy
- Sixth Nerve Palsy
- Synkinesis
- Ocular Motility Disorders
- Levator-Medial Rectus Synkinesis
- Athabaskan Brainstem Dysgenesis
- Tongue Paralysis
- Ninth Nerve Disorder
- Fifth Nerve Palsy
- Seventh Nerve Palsy
- Eleventh Nerve Disorder
- Twelfth Nerve Disorder
- Vagus Nerve Paralysis
- Moebius Sequence
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 1 Day and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2004
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
- Last update posted
- Feb 10, 2026
2004 – 2030
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03059420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03059420 live on ClinicalTrials.gov.